BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38223960)

  • 1. A Prognostic Model Based on Cisplatin-Resistance Related Genes in Oral Squamous Cell Carcinoma.
    Lu R; Yang Q; Liu S; Sun L
    Oral Health Prev Dent; 2024 Jan; 22(1):39-50. PubMed ID: 38223960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A four-hypoxia-genes-based prognostic signature for oral squamous cell carcinoma.
    Zhao C; Zhou Y; Ma H; Wang J; Guo H; Liu H
    BMC Oral Health; 2021 May; 21(1):232. PubMed ID: 33941139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.
    Chen Y; Feng Y; Yan F; Zhao Y; Zhao H; Guo Y
    Front Immunol; 2022; 13():922195. PubMed ID: 35935989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and validation of a metabolic-related genes prognostic model for oral squamous cell carcinoma based on bioinformatics.
    Zhang J; Ma C; Qin H; Wang Z; Zhu C; Liu X; Hao X; Liu J; Li L; Cai Z
    BMC Med Genomics; 2022 Dec; 15(1):269. PubMed ID: 36566175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
    Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
    BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and Analysis of Hypoxia-Related Model in Oral Squamous Cell Carcinoma.
    Lu X; Liu X
    J Healthc Eng; 2022; 2022():6602648. PubMed ID: 35432823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constructing a prognostic model for head and neck squamous cell carcinoma based on glucose metabolism related genes.
    Liu Y; Liu N; Zhou X; Zhao L; Wei W; Hu J; Luo Z
    Front Endocrinol (Lausanne); 2023; 14():1245629. PubMed ID: 37876534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a lncRNA-based prognostic signature for oral squamous cell carcinoma.
    Xu Z; Li X; Pan L; Tan R; Ji P; Tang H
    J Oral Pathol Med; 2022 Apr; 51(4):358-368. PubMed ID: 35100473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
    Guo H; Li C; Su X; Huang X
    Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
    [No Abstract]   [Full Text] [Related]  

  • 10. [MicroRNA model that can predict the prognosis of oral squamous cell carcinoma based on bioinformatics analysis].
    Zhao G; Li CX; Guo C; Zhu H
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2020 Dec; 38(6):622-627. PubMed ID: 33377337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a Gene Prognostic Signature for Oral Squamous Cell Carcinoma by RNA Sequencing and Bioinformatics.
    Zhang YY; Mao MH; Han ZX
    Biomed Res Int; 2021; 2021():6657767. PubMed ID: 33869632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prognostic Risk Score model for oral squamous cell carcinoma constructed by 6 glycolysis-immune-related genes.
    Liu Y; Wang T; Li R
    BMC Oral Health; 2022 Aug; 22(1):324. PubMed ID: 35922788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of an endoplasmic reticulum stress-related prognostic risk model with excellent prognostic and clinical value in oral squamous cell carcinoma.
    Cheng M; Fan X; He M; Dai X; Liu X; Hong J; Zhang L; Liao L
    Aging (Albany NY); 2023 Aug; 15(19):10010-10030. PubMed ID: 37647077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a novel senescence-related gene signature to predict clinical outcomes, immune landscape, and chemotherapeutic sensitivity in oral squamous cell carcinoma.
    Wang A; Xiao N; Wang H; Yao Q; Li J; Wu Y; Ge H; Diao P
    Head Neck; 2024 May; 46(5):1112-1125. PubMed ID: 38380567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of immune inflammation in head and neck squamous cell carcinoma: Tumor microenvironment, drug resistance, and clinical outcomes.
    Zhu L; Wang Y; Yuan X; Ma Y; Zhang T; Zhou F; Yu G
    Front Genet; 2022; 13():1085700. PubMed ID: 36579330
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification and verification of eight cancer-associated fibroblasts related genes as a prognostic signature for head and neck squamous cell carcinoma.
    Dong L; Sun Q; Song F; Song X; Lu C; Li Y; Song X
    Heliyon; 2023 Mar; 9(3):e14003. PubMed ID: 36938461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ferroptosis-related gene signature predicts the prognosis in Oral squamous cell carcinoma patients.
    Li H; Zhang X; Yi C; He Y; Chen X; Zhao W; Yu D
    BMC Cancer; 2021 Jul; 21(1):835. PubMed ID: 34284753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Insight into the role of IGF2BP1 in drug resistant mechanism of oral squamous cell carcinoma].
    Xie F; Qin X; Tong T; Jiang YY; Zhang JJ
    Shanghai Kou Qiang Yi Xue; 2021 Oct; 30(5):456-461. PubMed ID: 34888594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
    Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
    Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of TNF-alpha/NFkB/SIRT1 axis drives aggressiveness and cancer stem cells accumulation in chemoresistant oral squamous cell carcinoma.
    de Castro LR; de Oliveira LD; Milan TM; Eskenazi APE; Bighetti-Trevisan RL; de Almeida OGG; Amorim MLM; Squarize CH; Castilho RM; de Almeida LO
    J Cell Physiol; 2024 Feb; 239(2):e31164. PubMed ID: 38149816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.